MAPT and Alzheimer disease: Notably, these plants have demonstrated therapeutic potential in different cellular and animal models of neurodegenerative disorders including AD, in which they have been shown to improve cognitive deficits and reduce pathological characteristic markers such as tau protein and beta-amyloid accumulation.